"Trojan Horse" DNA Nanostructure for Personalized Theranostics : Can It Knock on the Door of Preclinical Practice?

Nanotheranostics, combing diagnostic and therapeutic components in an all-in-one nanomaterial, possess exciting potentials for precision nanomedicine. However, a major obstacle for current nanotheranostics to enter preclinical and/or clinical trials is the intrinsic toxicities of these nanomaterials...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 34(2018), 49 vom: 11. Dez., Seite 15028-15044
1. Verfasser: Li, Yuan (VerfasserIn)
Weitere Verfasser: Yang, Sheng, Zheng, Jing, Zou, Zhen, Yang, Ronghua, Tan, Weihong
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antineoplastic Agents Drug Carriers DNA 9007-49-2